HETERO LABS LIMITED
Location
Telangana
Founded
1989-03-10
Website
Risk Signals
263 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about HETERO LABS LIMITED
Live alerts from global media, monitored by Business Radar
2024-10-04 (biospectrumindia.com)
Dr. Reddy’s, Hetero sign voluntary licensing agreement with Gilead Sciences to transform global HIV response
Dr. Reddy’s, Hetero sign voluntary licensing agreement with Gilead Sciences to transform global HIV response
Read more
2024-10-03 (prnewswire.co.uk)
Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries
/PRNewswire/ -- Hetero, India's leading pharmaceutical company with the widest global reach, today announced a new partnership with Gilead Sciences Ireland UC...
Read more
2024-10-03 (thehindubusinessline.com)
Dr. Reddy’s and Hetero join hands with Gilead to broaden access to HIV drug Lenacapavir in low-income countries
Dr. Reddy’s and Hetero partner with Gilead Sciences to manufacture and distribute Lenacapavir for HIV treatment in LMICs.
Read more
2021-06-01 (indiatimes.com)
Hetero Biopharma gets nod for Sputnik phase-3 trials
The RDIF has signed agreements with several companies to manufacture Sputnik V in India — Virchow Biotech (up to 200 million doses per year) Gland Pharma (252 million doses) and Stelis Biopharma (200 million doses).
Read more
2021-04-27 (businesstoday.in)
Hetero-Merck alliance seeks emergency use nod for anti-COVID drug Molnupiravir in India
Under this licensing deal, Hetero will be allowed to sell Molnupiravir in India and in other low-and middle-income countries (LMICs), following the approvals for emergency use authorisation by local regulatory agencies
Read more
(economictimes.com)
Hyderabad's Hetero Group enters UAE with new venture
The first phase of the collaboration will be distribution of Hetero's medicines in the UAE, Chairman of Hetero Group B P S Reddy said.
Read more
(business-standard.com)
Hetero sets up Russia venture
Hetero Drugs, the Hyderabad-based active pharmaceutical ingredients and finished dosages manufacturer, has set up an equal stakes joint venture with Russian pharmaceutical major Makiz Pharma.
Read more